Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (131-140 of 525) with videos related to

Pageof 53
Sort By:
Clinical Nuclear Medicine|September 25, 2015
Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell CarcinomaSteven P Rowe, Michael A Gorin, Hans J Hammers, et al.
Magnetic Resonance in Medicine|January 10, 2008
Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approachesManus J Donahue, Jaishri O Blakeley, Jinyuan Zhou, et al.
European Journal of Medicinal Chemistry|April 30, 2016
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligandsMilan Subedi, Il Minn, Jianbo Chen, et al.
Toxicologic Pathology|December 15, 2010
Continuing education course #1: non-invasive imaging as a problem-solving tool and translational biomarker strategy in toxicologic pathologyRichard A Peterson, Kathy L Gabrielson, G Allan Johnson, et al.
Cancer Biology & Therapy|October 16, 2015
A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expressionJie Meng, Yuanyi Liu, Shuying Gao, et al.
Molecular Cancer Therapeutics|November 21, 2015
Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial AnaloguesCharles Zhu, Amey Bandekar, Michelle Sempkowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate CancerSteven P Rowe, Alexander Drzezga, Bernd Neumaier, et al.
AIDS (London, England)|May 11, 2018
Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapyLeah H Rubin, Ned Sacktor, Jason Creighton, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 30, 2025
Effective treatment of human prostate carcinoma xenografts with Single-Dose PSMA-targeted [<sup>211</sup>At]YF2Yutian Feng, Truc T Huynh, Yongxiang Zheng, et al.
Clinical Nuclear Medicine|January 23, 2018
Flare on Serial Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT Examinations in Castration-Resistant Prostate Cancer: First ObservationsKatherine A Zukotynski, John Valliant, François Bénard, et al.
Pageof 53

Showing results (131-140 of 525) with videos related to

Sort By:
Pageof 53
Clinical Nuclear Medicine|September 25, 2015
Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell CarcinomaSteven P Rowe, Michael A Gorin, Hans J Hammers, et al.
Magnetic Resonance in Medicine|January 10, 2008
Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approachesManus J Donahue, Jaishri O Blakeley, Jinyuan Zhou, et al.
European Journal of Medicinal Chemistry|April 30, 2016
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligandsMilan Subedi, Il Minn, Jianbo Chen, et al.
Toxicologic Pathology|December 15, 2010
Continuing education course #1: non-invasive imaging as a problem-solving tool and translational biomarker strategy in toxicologic pathologyRichard A Peterson, Kathy L Gabrielson, G Allan Johnson, et al.
Cancer Biology & Therapy|October 16, 2015
A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expressionJie Meng, Yuanyi Liu, Shuying Gao, et al.
Molecular Cancer Therapeutics|November 21, 2015
Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial AnaloguesCharles Zhu, Amey Bandekar, Michelle Sempkowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate CancerSteven P Rowe, Alexander Drzezga, Bernd Neumaier, et al.
AIDS (London, England)|May 11, 2018
Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapyLeah H Rubin, Ned Sacktor, Jason Creighton, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 30, 2025
Effective treatment of human prostate carcinoma xenografts with Single-Dose PSMA-targeted [<sup>211</sup>At]YF2Yutian Feng, Truc T Huynh, Yongxiang Zheng, et al.
Clinical Nuclear Medicine|January 23, 2018
Flare on Serial Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT Examinations in Castration-Resistant Prostate Cancer: First ObservationsKatherine A Zukotynski, John Valliant, François Bénard, et al.
Pageof 53